In a patient with recurrent yeast infections, which test is NOT indicated to assess immunocompromise?

Prepare for the PANCE Board Exam with our comprehensive quiz. Study with detailed questions and explanations. Sharpen your skills and boost your confidence for exam day!

Multiple Choice

In a patient with recurrent yeast infections, which test is NOT indicated to assess immunocompromise?

Explanation:
Evaluating recurrent yeast infections for immunocompromise focuses on conditions that directly undermine host defenses. Diabetes can impair neutrophil function and create an environment favorable to yeast, so checking long-term glycemic control with an A1c is helpful. HIV infection severely impairs cell-mediated immunity, so an HIV antibody test is important to assess immune status. The B-HCG test is a pregnancy marker and not a measure of immune competence, so it’s not about immune function. The ANA test screens for autoimmune diseases like lupus, which is not a direct test of immune readiness or predisposition to infections. Therefore, ANA is not indicated for assessing immunocompromise in this context.

Evaluating recurrent yeast infections for immunocompromise focuses on conditions that directly undermine host defenses. Diabetes can impair neutrophil function and create an environment favorable to yeast, so checking long-term glycemic control with an A1c is helpful. HIV infection severely impairs cell-mediated immunity, so an HIV antibody test is important to assess immune status. The B-HCG test is a pregnancy marker and not a measure of immune competence, so it’s not about immune function. The ANA test screens for autoimmune diseases like lupus, which is not a direct test of immune readiness or predisposition to infections. Therefore, ANA is not indicated for assessing immunocompromise in this context.

More practice questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy